PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)
Condition:   Prostate Cancer Intervention:   Other: Standard care plus exercise Sponsors:   University of East Anglia;   Norfolk and Norwich University Hospitals NHS Foundation Trust Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Estrogen Receptor Positive;   HER2/Neu Negative;   Metastatic Breast Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Progesterone Receptor Positive;   Prognostic Stage IV Breast Cancer AJCC v8 Interventions:   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant;   Drug: Letrozole;   Drug: Palbociclib;   Radiation: Radiation Therapy; &...
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal Therapy With Oral Dydrogesterone for Treatment of Confirmed Endometriosis (ORCHIDEA)
Condition:   Endometriosis Intervention:   Drug: Duphaston® (Dydrogesterone) Sponsor:   Abbott Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2018 Category: Research Source Type: clinical trials

Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
Condition:   Growth Hormone Deficiency in Children Intervention:   Other: No treatment given Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2018 Category: Research Source Type: clinical trials

Systemic Light Exposure in Preventing Frailty in Older Participants With Prostate Cancer on Hormonal Therapy
Condition:   Prostate Carcinoma Interventions:   Device: Actigraph;   Other: Questionnaire Administration;   Procedure: Systematic Light Exposure Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2018 Category: Research Source Type: clinical trials